NYSE:INSP Inspire Medical Systems (INSP) Stock Price, News & Analysis → Elon Musk’s PRIME is Set to Shock the World (From InvestorPlace) (Ad) Free INSP Stock Alerts $155.22 -3.81 (-2.40%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$152.90▼$159.4850-Day Range$155.22▼$251.2252-Week Range$123.27▼$330.00Volume770,357 shsAverage Volume780,919 shsMarket Capitalization$4.61 billionP/E RatioN/ADividend YieldN/APrice Target$256.53 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Inspire Medical Systems alerts: Email Address Inspire Medical Systems MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.69 Rating ScoreUpside/Downside65.3% Upside$256.53 Price TargetShort InterestHealthy7.74% of Shares Sold ShortDividend StrengthN/ASustainability-0.66Upright™ Environmental ScoreNews Sentiment1.18Based on 7 Articles This WeekInsider TradingSelling Shares$15.66 M Sold Last QuarterProj. Earnings Growth406.25%From $0.16 to $0.81 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.91 out of 5 starsMedical Sector26th out of 918 stocksSurgical & Medical Instruments Industry5th out of 98 stocks 4.3 Analyst's Opinion Consensus RatingInspire Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.69, and is based on 11 buy ratings, 5 hold ratings, and no sell ratings.Amount of Analyst CoverageInspire Medical Systems has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Inspire Medical Systems' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted7.74% of the outstanding shares of Inspire Medical Systems have been sold short.Short Interest Ratio / Days to CoverInspire Medical Systems has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Inspire Medical Systems has recently decreased by 0.43%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldInspire Medical Systems does not currently pay a dividend.Dividend GrowthInspire Medical Systems does not have a long track record of dividend growth. Previous Next 4.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreInspire Medical Systems has received a 78.27% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Neurostimulators" and "Medical technology engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Inspire Medical Systems is -0.66. Previous Next 2.9 News and Social Media Coverage News SentimentInspire Medical Systems has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Inspire Medical Systems this week, compared to 7 articles on an average week.Search InterestOnly 10 people have searched for INSP on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.MarketBeat Follows9 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. This is an increase of 350% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inspire Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,664,278.00 in company stock.Percentage Held by InsidersOnly 4.10% of the stock of Inspire Medical Systems is held by insiders.Percentage Held by Institutions94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inspire Medical Systems' insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Inspire Medical Systems are expected to grow by 406.25% in the coming year, from $0.16 to $0.81 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inspire Medical Systems is -282.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inspire Medical Systems is -282.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInspire Medical Systems has a P/B Ratio of 7.83. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Inspire Medical Systems' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… About Inspire Medical Systems Stock (NYSE:INSP)Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.Read More INSP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INSP Stock News HeadlinesApril 19, 2024 | insidertrades.comInspire Medical Systems, Inc. (NYSE:INSP) CFO Sells $3,450,450.00 in StockMay 16 at 3:16 AM | americanbankingnews.comAlpha Tau Medical (NASDAQ:DRTS) vs. Inspire Medical Systems (NYSE:INSP) Critical SurveyMay 12, 2024 | americanbankingnews.comBank of America Lowers Inspire Medical Systems (NYSE:INSP) to NeutralMay 11, 2024 | americanbankingnews.comInspire Medical Systems, Inc. Forecasted to Earn Q2 2024 Earnings of ($0.04) Per Share (NYSE:INSP)May 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Inspire Medical Systems Amid Robust Overseas Sales and Upbeat Full-Year GuidanceMay 10, 2024 | finance.yahoo.comThe Inspire Medical Systems, Inc. (NYSE:INSP) First-Quarter Results Are Out And Analysts Have Published New ForecastsMay 10, 2024 | americanbankingnews.comFY2027 Earnings Estimate for Inspire Medical Systems, Inc. (NYSE:INSP) Issued By Leerink PartnrsMay 10, 2024 | americanbankingnews.comInspire Medical Systems (NYSE:INSP) Given New $255.00 Price Target at Piper SandlerMay 9, 2024 | msn.comEssential medical device maker files Chapter 11 bankruptcyMay 9, 2024 | americanbankingnews.comInspire Medical Systems, Inc. (NYSE:INSP) Given Average Rating of "Moderate Buy" by AnalystsMay 8, 2024 | msn.comCrude Oil Moves Higher; Inspire Medical Systems Shares PlummetMay 8, 2024 | markets.businessinsider.comInspire Medical Systems: Hold Rating Amidst Slowing Growth and Profitability ConcernsMay 8, 2024 | finance.yahoo.comInspire Medical Systems, Inc. (NYSE:INSP) Q1 2024 Earnings Call TranscriptMay 7, 2024 | markets.businessinsider.comINSP Stock Earnings: Inspire Medical Systems Beats EPS, Beats Revenue for Q1 2024May 7, 2024 | finance.yahoo.comInspire Medical Systems Inc (INSP) Surpasses Revenue Estimates and Narrows Quarterly LossMay 7, 2024 | washingtonpost.comInspire: Q1 Earnings SnapshotMay 7, 2024 | globenewswire.comInspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 OutlookMay 6, 2024 | finance.yahoo.comWill These 5 Medical Device Stocks Beat This Earnings Season?May 2, 2024 | msn.comMotor neurone disease ALS: Hong Kong patients inspire fundraising that helps city researchers looking for a cureMay 1, 2024 | msn.comGundersen Health System and Bellin Health announce re-brandingApril 30, 2024 | finance.yahoo.comInspire Medical Systems (INSP) Stock Moves -0.8%: What You Should KnowApril 30, 2024 | finance.yahoo.comInspire Medical Systems Stock Sees IBD RS Rating Rise To 78April 30, 2024 | globenewswire.comInspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care ConferenceApril 29, 2024 | benzinga.comWhat the Options Market Tells Us About Inspire Medical SystemsApril 24, 2024 | finance.yahoo.comInspire Agency Announces SHL Medical, Greenwood Genetic Center and SCbio as its Newest Life Science ClientsSee More Headlines Receive INSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today5/18/2024Next Earnings (Estimated)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:INSP CUSIPN/A CIK1609550 Webwww.inspiresleep.com Phone(844) 672-4357FaxN/AEmployees1,011Year FoundedN/APrice Target and Rating Average Stock Price Target$256.53 High Stock Price Target$371.00 Low Stock Price Target$159.00 Potential Upside/Downside+65.3%Consensus RatingModerate Buy Rating Score (0-4)2.69 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)($0.55) Trailing P/E RatioN/A Forward P/E Ratio970.13 P/E GrowthN/ANet Income$-21,150,000.00 Net Margins-2.38% Pretax Margin-2.13% Return on Equity-2.82% Return on Assets-2.40% Debt Debt-to-Equity RatioN/A Current Ratio7.93 Quick Ratio7.25 Sales & Book Value Annual Sales$624.80 million Price / Sales7.38 Cash FlowN/A Price / Cash FlowN/A Book Value$19.83 per share Price / Book7.83Miscellaneous Outstanding Shares29,710,000Free Float28,493,000Market Cap$4.61 billion OptionableOptionable Beta1.35 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Timothy P. Herbert (Age 61)CEO, President & Director Comp: $1.36MMr. Richard J. Buchholz (Age 56)Chief Financial Officer Comp: $663.43kMr. Philip J. Ebeling (Age 53)Chief Operating Officer Comp: $675.41kMr. Randall A. Ban (Age 59)Chief Commercial Officer Comp: $624.45kDr. Charisse Y. Sparks FAAOS (Age 61)M.D., Chief Medical Officer Comp: $31.35kMr. Carlton W. Weatherby (Age 39)Chief Strategy Officer Comp: $553.29kMr. John C. Rondoni (Age 44)Chief Technology Officer Comp: $576.72kMs. Ezgi YagciVice President of Investor RelationsMr. Bryan K. Phillips (Age 53)Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary Comp: $639.9kMr. Steven L. Jandrich (Age 57)Vice President of Human Resources Comp: $417.22kMore ExecutivesKey CompetitorsMerit Medical SystemsNASDAQ:MMSIHaemoneticsNYSE:HAEGlaukosNYSE:GKOSAxonicsNASDAQ:AXNXPROCEPT BioRoboticsNASDAQ:PRCTView All CompetitorsInsiders & InstitutionsComerica BankBought 8,454 shares on 5/17/2024Ownership: 0.266%Walleye Trading LLCBought 15,100 shares on 5/17/2024Ownership: 0.000%Tidal Investments LLCBought 5,361 shares on 5/17/2024Ownership: 0.018%California State Teachers Retirement SystemSold 1,388 shares on 5/16/2024Ownership: 0.099%Bayesian Capital Management LPBought 2,347 shares on 5/16/2024Ownership: 0.008%View All Insider TransactionsView All Institutional Transactions INSP Stock Analysis - Frequently Asked Questions Should I buy or sell Inspire Medical Systems stock right now? 16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 5 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" INSP shares. View INSP analyst ratings or view top-rated stocks. What is Inspire Medical Systems' stock price target for 2024? 16 equities research analysts have issued 12-month price objectives for Inspire Medical Systems' stock. Their INSP share price targets range from $159.00 to $371.00. On average, they predict the company's share price to reach $256.53 in the next twelve months. This suggests a possible upside of 65.3% from the stock's current price. View analysts price targets for INSP or view top-rated stocks among Wall Street analysts. How have INSP shares performed in 2024? Inspire Medical Systems' stock was trading at $203.43 at the beginning of 2024. Since then, INSP stock has decreased by 23.7% and is now trading at $155.22. View the best growth stocks for 2024 here. When is Inspire Medical Systems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 6th 2024. View our INSP earnings forecast. How were Inspire Medical Systems' earnings last quarter? Inspire Medical Systems, Inc. (NYSE:INSP) released its earnings results on Tuesday, May, 7th. The company reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.63) by $0.29. The company had revenue of $164.01 million for the quarter, compared to the consensus estimate of $161.41 million. Inspire Medical Systems had a negative trailing twelve-month return on equity of 2.82% and a negative net margin of 2.38%. The firm's revenue was up 28.2% on a year-over-year basis. During the same quarter last year, the company earned ($0.53) EPS. What ETFs hold Inspire Medical Systems' stock? ETFs with the largest weight of Inspire Medical Systems (NYSE:INSP) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Fidelity Digital Health ETF (FDHT), Alger Weatherbie Enduring Growth ETF (AWEG), BNY Mellon Innovators ETF (BKIV), SPDR S&P Health Care Equipment ETF (XHE), American Century Mid Cap Growth Impact (MID), Fidelity Disruptive Medicine ETF (FMED) and Harbor Health Care ETF (MEDI). What guidance has Inspire Medical Systems issued on next quarter's earnings? Inspire Medical Systems updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of 0.100-0.200 for the period, compared to the consensus EPS estimate of -0.360. The company issued revenue guidance of $783.0 million-$793.0 million, compared to the consensus revenue estimate of $782.3 million. What is Tim Herbert's approval rating as Inspire Medical Systems' CEO? 2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Inspire Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ). When did Inspire Medical Systems IPO? Inspire Medical Systems (INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers. Who are Inspire Medical Systems' major shareholders? Inspire Medical Systems' stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.55%), Baillie Gifford & Co. (4.84%), Wasatch Advisors LP (3.64%), William Blair Investment Management LLC (2.50%), Champlain Investment Partners LLC (2.16%) and Bank of New York Mellon Corp (1.97%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View institutional ownership trends. How do I buy shares of Inspire Medical Systems? Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:INSP) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsProtect Your Bank Account Before It’s Too LateWeiss RatingsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
